The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Abstract
BACKGROUND: We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. METHODS: A total of 1520 patients who had advanced heart failure (New York Heart Association class III or IV) due to ischemic or nonischemic cardiomyopathies and a QRS interval of at least 120 msec were randomly assigned in a 1:2:2 ratio to receive optimal pharmacologic therapy (diuretics, angiotensin-converting-enzyme inhibitors, beta-blockers, and spironolactone) alone or in combination with cardiac-resynchronization therapy with either a pacemaker or a pacemaker-defibrillator. The primary composite end point was the time to death from or hospitalization for any cause. RESULTS: As compared with optimal pharmacologic therapy alone, cardiac-resynchronization therapy with a pacemaker decreased the risk of the primary end point (hazard ratio, 0.81; P=0.014), as did cardiac-resynchronization therapy with a pacemaker-defibrillator (hazard ratio, 0.80; P=0.01). The risk of the combined end point of death from or hospitalization for heart failure was reduced by 34 percent in the pacemaker group (P<0.002) and by 40 percent in the pacemaker-defibrillator group (P<0.001 for the comparison with the pharmacologic-therapy group). A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker-defibrillator reduced the risk by 36 percent (P=0.003). CONCLUSIONS: In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While clinical improvements are generally achieved, six-month nonresponder rates have been reported to be as high as 32–43%11,13, which is partially attributed to anatomic constraints of lead positioning14.”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [13]
In the citing paper
“Device therapies (implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT], and CRT with an implantable defibrillator [CRT-D]) have similar efficacies and risks in patients with HFrEF with or without diabetes.[522][523][524][525]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [524]
Citations
Cites
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
CARDIAC RESYNCHRONIZATION IN CHRONIC HEART FAILURE
Braham, W. I. T. A., Isher, W. E. G. F., Mith, L. S., Elurgio, D. A. B. D., Eon, A. N. R. L., Oh, E., Ocovic, D. U. Z. K., Acker, M. G., Lavell, L. C., Ayes, D. A. L. H., et al. (2002) · Cited by 3,808
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Self-citationDiscrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Self-citationSt John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Auricchio, A., Stellbrink, C., Sack, S., Block, M., Vogt, J. Ü., Bakker, P., Huth, C., Schöndube, F., Wolfhard, U., Böcker, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01895-8 · Cited by 1,026
Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., McKenna, W., Fitzgerald, M., Deharo, J.-C., Alonso, C., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01932-0 · Cited by 973
Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121264 · Cited by 800
Cited by
Items 301–400 of 1,014
III Diretriz Brasileira de Insuficiência Cardíaca Crônica
Bocchi, E. A., Marcondes‐Braga, F. G., Ayub‐Ferreira, S. M., Rohde, L. E. P., Junior, W. A. D. O., Almeida, D. R., Moreira, M. D. C. V., Bestetti, R. B., Bordignon, S., Azevedo, C., et al. (2009) · Americanae (AECID Library) · doi:10.1590/s0066-782x2009002000001 · Cited by 170
Goldstein, N. E., Mehta, D., Siddiqui, S., Teitelbaum, E., Zeidman, J., Singson, M., Pe, E., Bradley, E. H., & Morrison, R. S. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0239-8 · Cited by 174
Diastolic and Systolic Asynchrony in Patients With Diastolic Heart Failure
Yu, C.-M., Zhang, Q., Yip, G. W. K., Lee, P.-W., Kum, L. C. C., Lam, Y.-Y., & Fung, J. W.-H. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.022 · Cited by 172
Ezekowitz, J. A., Rowe, B. H., Dryden, D. M., Hooton, N., Vandermeer, B., Spooner, C., & McAlister, F. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00007 · Cited by 172
Lim, P., Buakhamsri, A., Popovic, Z. B., Greenberg, N. L., Patel, D., Thomas, J. D., & Grimm, R. A. (2008) · Circulation · doi:10.1161/circulationaha.107.750190 · Cited by 172
Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial Fibrillation
Chung, M. K., Shemanski, L., Sherman, D. G., Greene, H. L., Hogan, D. B., Kellen, J. C., Kim, S. G., Martin, L. W., Rosenberg, Y., & Wyse, D. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.040 · Cited by 173
Sharma, P. S., Naperkowski, A., Bauch, T. D., Chan, J. Y. S., Arnold, A. D., Whinnett, Z. I., Ellenbogen, K. A., & Vijayaraman, P. (2018) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006613 · Cited by 170
Clinical outcomes with synchronized left ventricular pacing: Analysis of the adaptive CRT trial
Birnie, D., Lemke, B., Aonuma, K., Krum, H., Lee, K. L.-F., Gasparini, M., Starling, R. C., Milasinovic, G., Gorcsan, J., Houmsse, M., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.007 · Cited by 170
Gras, D., Böcker, D., Lunati, M., Wellens, H. J. J., Calvert, M., Freemantle, N., Gervais, R., Kappenberger, L., Tavazzi, L., Erdmann, E., et al. (2007) · EP Europace · doi:10.1093/europace/eum080 · Cited by 172
Piccirillo, G., Magri, D., Matera, S., Magnanti, M., Torrini, A., Pasquazzi, E., Schifano, E., Velitti, S., Marigliano, V., Quaglione, R., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl367 · Cited by 170
Healey, J. S., Hallstrom, A. P., Kuck, K.-H., Nair, G., Schron, E. P., Roberts, R. S., Morillo, C. A., & Connolly, S. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl438 · Cited by 170
Krum, H., Jelinek, M. V., Stewart, S., Sindone, A., Atherton, J. J., & Hawkes, A. L. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00690.x · Cited by 169
20 Years of Cardiac Resynchronization Therapy
Leyva, F., Nisam, S., & Auricchio, A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1178 · Cited by 169
Leitlinien zur Therapie der chronischen Herzinsuffizienz
Hoppe, U. C., Böhm, M., Dietz, R., Hanrath, P., Kroemer, H. K., Osterspey, A., Schmaltz, A. A., & Erdmann, E. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0268-4 · Cited by 169
Santangeli, P., Pelargonio, G., Russo, A. D., Casella, M., Bisceglia, C., Bartoletti, S., Santarelli, P., Di Biase, L., & Natale, A. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.03.042 · Cited by 168
Singh, J. P., Hall, W. J., McNitt, S., Wang, H., Daubert, J. P., Zareba, W., Ruskin, J. N., & Moss, A. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.088 · Cited by 168
Richardson, M., Freemantle, N., Calvert, M. J., Cleland, J. G. F., Tavazzi, L., & on behalf of the CARE-HF Study Steering Committee and Investigators (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm192 · Cited by 167
Kusumoto, F. M., Calkins, H., Boehmer, J., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J., Lee, R., Mehra, M. R., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.008 · Cited by 167
Self-citationWikstrom, G., Blomstrom-Lundqvist, C., Andren, B., Lonnerholm, S., Blomstrom, P., Freemantle, N., Remp, T., Cleland, J. G. F., & on behalf of the CARE-HF study investigators (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn577 · Cited by 168
Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators
Santangeli, P., Di Biase, L., Russo, A. D., Casella, M., Bartoletti, S., Santarelli, P., Pelargonio, G., & Natale, A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00009 · Cited by 167
Masci, P. G., Schuurman, R., Andrea, B., Ripoli, A., Coceani, M., Chiappino, S., Todiere, G., Srebot, V., Passino, C., Aquaro, G. D., et al. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.113.000438 · Cited by 164
Cui, Z., Ni, N. C., Wu, J., Du, G.-Q., He, S., Yau, T. M., Weisel, R. D., Sung, H.-W., & Li, R.-K. (2018) · Theranostics · doi:10.7150/thno.22599 · Cited by 162
“The resulting abnormal conduction may contribute to morbidity and mortality following an MI [27].”
Background3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure
Mack, M. J., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B. K., Grayburn, P. A., Rinaldi, M. J., Kapadia, S. R., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.047 · Cited by 165
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
Nogami, A., Kurita, T., Abe, H., Ando, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 164
Theuns, D. A. M. J., Smith, T., Hunink, M. G. M., Bardy, G. H., & Jordaens, L. (2010) · Europace · doi:10.1093/europace/euq329 · Cited by 164
“The Multicenter Unsustained Tachycardia Trial (MUSTT) and the Comparison of Medical Therapy, Pacing and Defibrillators in Chronic Heart Failure (COMPANION) trial were excluded from the analysis.(21,22) The MUSTT trial was not a randomized controlled trial of ICD therapy, but compared with electrophysiological study gu…”
Cardiac Arrest and Sudden Cardiac Death
Myerburg, R. J., & Castellanos, A. (2012) · Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine · doi:10.1016/b978-1-4377-0398-6.00041-x · Cited by 163
Tracy, C. M., Epstein, A. E., Darbar, D., DiMarco, J. P., Dunbar, S. B., Estes, N. A. M., Ferguson, T. B., Hammill, S. C., Karasik, P. E., Link, M. S., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.08.021 · Cited by 162
Thibault, B., Harel, F., Ducharme, A., White, M., Ellenbogen, K. A., Frasure-Smith, N., Roy, D., Philippon, F., Dorian, P., Talajic, M., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001239 · Cited by 162
Kass, D. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.027 · Cited by 161
Self-citationPowell, B. D., Saxon, L. A., Boehmer, J. P., Day, J. D., Gilliam, F. R., Heidenreich, P. A., Jones, P. W., Rousseau, M. J., & Hayes, D. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.083 · Cited by 162
Self-citationCardiomyopathy, familial dilated
Taylor, M. R., Carniel, E., & Mestroni, L. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-27 · Cited by 159
“In the COMPANION trial [36] CRT reduced the risk of death and hospitalization for any cause by approximately 20%, with a 50% reduction in the risk of death for any cause in the subgroup of patients with non-ischemic DCM randomized to receive CRT + defibrillator.”
BackgroundPacker, M., & McMurray, J. J. V. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2149 · Cited by 160
Becker, M., Kramann, R., Franke, A., Breithardt, O.-A., Heussen, N., Knackstedt, C., Stellbrink, C., Schauerte, P., Kelm, M., & Hoffmann, R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm034 · Cited by 159
Greenberg, B., Yaroshinsky, A., Zsebo, K. M., Butler, J., Felker, G. M., Voors, A. A., Rudy, J. J., Wagner, K., & Hajjar, R. J. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.09.008 · Cited by 158
Kuriachan, V. P., Sumner, G., & Mitchell, L. B. (2015) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2015.01.002 · Cited by 192
“The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial randomized 1520 patients in a with advanced heart failure and a QRS duration >120 msec to receive either medical therapy alone, medical therapy with a cardiac resynchronization therapy (CRT) pacemaker, or medical therapy w…”
MethodElectrical remodeling in the failing heart
Aiba, T., & Tomaselli, G. F. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328333d3d6 · Cited by 166
“[60] On the other hand, in patients treated with CRT defibrillators, ventricular arrhythmias were reduced during the initial 12 months after implant.”
BackgroundBoogers, M. M., Van Kriekinge, S. D., Henneman, M. M., Ypenburg, C., Van Bommel, R. J., Boersma, E., Dibbets-Schneider, P., Stokkel, M. P., Schalij, M. J., Berman, D. S., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060657 · Cited by 158
“Moreover, CRT resulted in a superior survival rate, with a reduction in heart failure hospitalization rate (3, 4 ).”
BackgroundKrum, H., & Abraham, W. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60236-1 · Cited by 159
Fully Bioabsorbable Capacitor as an Energy Storage Unit for Implantable Medical Electronics
Li, H., Zhao, C., Wang, X., Meng, J., Zou, Y., Noreen, S., Zhao, L., Liu, Z., Ouyang, H., Tan, P., et al. (2019) · Advanced Science · doi:10.1002/advs.201801625 · Cited by 161
Müllens, W., Auricchio, A., Martens, P., Witte, K. K., Cowie, M., Delgado, V., Dickstein, K., Linde, C. M., Vernooy, K., Leyva, F., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2046 · Cited by 174
Lumens, J., Tayal, B., Walmsley, J., Delgado-Montero, A., Huntjens, P. R., Schwartzman, D. A., Althouse, A. D., Delhaas, T., Prinzen, F. W., & Gorcsan, J. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003744 · Cited by 158
Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy
Birnie, D. H., Ha, A. C. T., Higginson, L., Sidhu, K., Green, M. S., Philippon, F., Thibault, B., Wells, G. A., & Tang, A. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000380 · Cited by 155
Olsen, C. R., Mentz, R. J., Anstrom, K. J., Page, D. I., & Patel, P. A. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.07.009 · Cited by 189
Achilli, A., Peraldo, C., Sassara, M., Orazi, S., Bianchi, S., Laurenzi, F., DONATI, R., Perego, G. B., Spampinato, A., Valsecchi, S., et al. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00486.x · Cited by 150
“The 30% nonresponder rate to CRT is high,2 and is probably related to several factors: (1) The indirect and inaccurate estimation of mechanical LV dyssynchrony, based on QRS duration; (2) the lack of adequate resynchronization, possibly due to inappropriate LV pacing site; (3) suboptimal device programming; (4) the pr…”
BackgroundTrimble, M. A., Velazquez, E. J., Adams, G. L., Honeycutt, E. F., Pagnanelli, R., Barnhart, H. X., Chen, J., Iskandrian, A. E., Garcia, E. V., & Borges‐Neto, S. (2008) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3282f81380 · Cited by 155
Cleland, J. G. F., Freemantle, N., Erdmann, E., Gras, D., KAPPENBERGER, L. J., Tavazzi, L., & Daubert, J. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs055 · Cited by 159
End-of-Life Care in Patients With Heart Failure
Whellan, D. J., Goodlin, S. J., Dickinson, M. G., Heidenreich, P. A., Jaenicke, C., Stough, W. G., & Rich, M. W. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.12.003 · Cited by 177
Effects of active and passive tobacco cigarette smoking on heart rate variability
Dinas, P. C., Koutedakis, Y., & Flouris, A. D. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.10.140 · Cited by 164
Pappone, C., Ćalović, Ž., Vicedomini, G., Cuko, A., McSpadden, L. C., Ryu, K., Romano, E., Saviano, M., Baldi, M., Pappone, A., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.11.023 · Cited by 150
“Landmark clinical trials have demonstrated that cardiac resynchronization therapy (CRT) in patients with prolonged QRS duration and reduced ejection fraction (EF) can reverse the progression of heart failure and reduce mortality.(1,2) However, up to 40% of the patients fail to clinically respond to conventional therap…”
BackgroundAcosta, J., Fernández‐Armenta, J., Borràs, R., Anguera, I., Bisbal, F., Martí‐Almor, J., Tolosana, J. M., Penela, D., Andreu, D., Soto‐Iglesias, D., et al. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.04.021 · Cited by 155
“Given that life-threatening VA has a low incidence in PP CRT patients (1,4), better risk-stratification tools are required.”
BackgroundMethodInfluentialFerrari, G. M. D., Stolen, C., Tuinenburg, A. E., Wright, D. J., Brugada, J., Butter, C., Klein, H., Neužil, P., Botman, C. J., Castel, M., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.06.036 · Cited by 153
Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011): Digest Version
JCS Joint Working Group (2012) · Circulation Journal · doi:10.1253/circj.cj-66-0054 · Cited by 161
A Dimorphic Fungus Causing Disseminated Infection in South Africa
Kenyon, C. R., Bonorchis, K., Corcoran, C., Meintjes, G., Locketz, M. L., Lehloenya, R. J., Vismer, H. F., Naicker, P. R., Prozesky, H. W., Wyk, M. V., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215460 · Cited by 157
Grammes, J. A., Schulze, C., Al-Bataineh, M., Yesenosky, G. A., Saari, C. S., Vrabel, M. J., Horrow, J. C., Chowdhury, M., Fontaine, J. M., & Kutalek, S. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.034 · Cited by 149
“del Rio, 2003 (29) 5‡ Surgical 40% (2) 40”
Heywood, J. T., Jermyn, R. A., Shavelle, D. M., Abraham, W. T., Bhimaraj, A., Bhatt, K. A., Sheikh, F., Eichhorn, E. J., Lamba, S., Bharmi, R., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026184 · Cited by 154
Increasing Participation of Women in Cardiovascular Trials
Cho, L., Vest, A. R., O’Donoghue, M. L., Ogunniyi, M. O., Sarma, A. A., Denby, K. J., Lau, E. S., Poole, J. E., Lindley, K. J., & Mehran, R. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.022 · Cited by 153
Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease
Borleffs, C. J. W., Scherptong, R. W. C., Man, S., van Welsenes, G. H., Bax, J. J., van Erven, L., Swenne, C. A., & Schalij, M. J. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.859108 · Cited by 148
2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR Appropriate Utilization of Cardiovascular Imaging in Heart Failure
Patel, M. R., White, R. D., Abbara, S., Bluemke, D. A., Herfkens, R. J., Picard, M. H., Shaw, L. J., Silver, M. A., Stillman, A. E., & Udelson, J. E. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.005 · Cited by 149
Fantoni, C., Raffa, S., Regoli, F. D., Giraldi, F., Rovere, M. T. L., Prentice, J., Pastori, F., Fratini, S., Salerno‐Uriarte, J. A., Klein, H., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.081 · Cited by 145
ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Nielsen, J. C., Petersen, H. H., Karlsen, F. M., Chri, L. S., & Haarbo, J. (2014) · Cited by 146
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.05.007 · Cited by 145
Influence of Left Ventricular Lead Location on Outcomes in the COMPANION Study
Saxon, L. A., Olshansky, B., VOLOSIN, K. J., Steinberg, J. S., Lee, B. K., TOMASSONI, G. F., Guarnieri, T., Rao, A., YONG, P., Galle, E. G., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01444.x · Cited by 142
Self-citationPotential Proarrhythmic Effects of Biventricular Pacing
Fish, J. M., Brugada, J., & Antzelevitch, C. N. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.035 · Cited by 144
Vijayaraman, P., Zalavadia, D., Haseeb, A., Dye, C. A., Madan, N., Skeete, J., Vipparthy, S. C., Young, W., Ravi, V., Rajakumar, C. J., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.04.023 · Cited by 148
Understanding Nonresponders of Cardiac Resynchronization Therapy—Current and Future Perspectives
Yu, C., Fung, J. W., Zhang, Q., & Sanderson, J. E. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.40829.x · Cited by 142
Rationale and study design of the INcrease Of Vagal TonE in Heart Failure study: INOVATE-HF
Hauptman, P. J., Schwartz, P. J., Gold, M. R., Borggrefe, M., van Veldhuisen, D. J., Starling, R. C., & Mann, D. L. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.03.021 · Cited by 152
Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
Woods, B. S., Hawkins, N., Mealing, S., Sutton, A. J., Abraham, W. T., Beshai, J. F., Klein, H., Sculpher, M., Plummer, C., & Cowie, M. (2015) · Heart · doi:10.1136/heartjnl-2015-307634 · Cited by 155
Fruhwald, F. M., Fahrleitner‐Pammer, A., Berger, R., Leyva, F., Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L., Daubert, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl505 · Cited by 142
Leclercq, C., Cazeau, S., LELLOUCHE, D., FOSSATI, F., Anselme, F., Davy, J., Sadoul, N., Klug, D., MOLLO, L., & Daubert, J. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00598.x · Cited by 153
“The patients were eligible for inclusion in the study if they fulfilled the following criteria: (1) New York Heart Association (NYHA) functional classes III or IV for ≥1 month despite optimized medical treatment, including diuretics, angiotensin-converting enzyme inhibitors, and beta-adrenergic blockers in the highest…”
BackgroundMethodTanaka, H., Hara, H., Saba, S., & Gorcsan, J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.09.010 · Cited by 145
Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials
Wells, G. A., Parkash, R., Healey, J. S., Talajic, M. R., Arnold, J. M. O., Sullivan, S., Peterson, J., Yetisir, E., Theoret-Patrick, P., Luce, M., et al. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101685 · Cited by 140
“Five trials compared cardiac resynchronization therapy plus optimal therapy (n = 1342) with optimal medical therapy alone (n = 1013).(20,21,24,26,27) Seven trials compared cardiac resynchronization therapy and an implantable defibrillator (n = 2902) with an implantable defibrillator (n = 2281).”
BackgroundMethodLeft Bundle Branch Block: Current and Future Perspectives
Tan, N. Y. L., Witt, C. M., Oh, J. K., & Cha, Y. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.008239 · Cited by 175
Whinnett, Z. I., Davies, J. E., Willson, K., Manisty, C., CHOW, A. W. C., Foale, R. A., Davies, D. W., Hughes, A. D., Mayet, J., & Francis, D. P. (2006) · Heart · doi:10.1136/hrt.2005.080721 · Cited by 139
Meta-analysis: Cardiac Resynchronization Therapy for Patients With Less Symptomatic Heart Failure
Al-Majed, N. S., McAlister, F. A., Bakal, J. A., & Ezekowitz, J. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-6-201103150-00313 · Cited by 139
Delnoy, P. P. H. M., Ottervanger, J. P., Luttikhuis, H. O., Elvan, A., Misier, A. R. R., Beukema, W. P., & van Hemel, N. M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.12.040 · Cited by 136
Tan, V. H., Wilton, S. B., Kuriachan, V. P., Sumner, G., & Exner, D. V. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001217 · Cited by 140
“3 Introduction Implantable cardioverter defibrillator (ICD) therapy is effective in reducing mortality in patients with left ventricular dysfunction and symptoms of heart failure.(1-6) Non-essential ICD therapies, include those unrelated to a sustained ventricular tachyarrhythmia.”
BackgroundWhat causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
Packer, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz553 · Cited by 155
McKelvie, R. S., Moe, G. W., Ezekowitz, J. A., Heckman, G. A., Costigan, J., Ducharme, A., Estrella-Holder, E., Giannetti, N., Grzeslo, A., Harkness, K., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.10.007 · Cited by 208
Thibault, B., Dubuc, M., Khairy, P., Guerra, P. G., Macle, L., Rivard, L., Roy, D., Talajic, M. R., Karst, E., Ryu, K., et al. (2013) · EP Europace · doi:10.1093/europace/eus435 · Cited by 137
Risk Factors for Mortality in Patients With Cardiac Device-Related Infection
Baman, T. S., Gupta, S. K., Valle, J. A., & Yamada, E. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.816868 · Cited by 139
“Pulmonary embolism 9 (4) 5 (3) 4 (11) 3.”
Surges, R., Taggart, P. I., Sander, J. W. A. S., & Walker, M. C. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02571.x · Cited by 140
Penn, M. S., Mendelsohn, F. O., Schaer, G. L., Sherman, W., FARR, M. A., Pastore, J., Rouy, D., Clemens, R., Aras, R. A., & Losordo, D. W. (2013) · Circulation Research · doi:10.1161/circresaha.111.300440 · Cited by 138
Electrical resynchronization induced by direct His-bundle pacing
Lustgarten, D. L., Calame, S., Crespo, E. M., Calame, J., Lobel, R. M., & Spector, P. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.09.066 · Cited by 135
CKD and Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapeutic Approaches
Whitman, I. R., Feldman, H. I., & Deo, R. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010037 · Cited by 134
Advanced ICD Troubleshooting: Part I
Swerdlow, C. D., & Friedman, P. A. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00275.x · Cited by 138
Cardiac pacing: the state of the art
Trohman, R. G., Kim, M. H., & Pinski, S. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17358-3 · Cited by 147
Sachse, F. B., Torres, N. S., Galimberti, E. S., Aiba, T., Kass, D. A., Tomaselli, G. F., & Bridge, J. H. B. (2012) · Circulation Research · doi:10.1161/circresaha.111.257428 · Cited by 132
Self-citationChalil, S., Stegemann, B., Muhyaldeen, S., Khadjooi, K., Foley, P. W. X., Smith, R., & Leyva, F. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00841.x · Cited by 131
van Veldhuisen, D. J., Maass, A. H., Priori, S. G., Stolt, P., Gelder, I. C. V., Dickstein, K., & Swedberg, K. B. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp149 · Cited by 132
Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial
Calvert, M., Freemantle, N., Yao, G., Cleland, J. G. F., Billingham, L. J., Daubert, J., & Bryan, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi662 · Cited by 133
Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131
New York Heart Association functional class predicts exercise parameters in the current era
Russell, S. D., Saval, M. A., Robbins, J. L., Ellestad, M., Gottlieb, S. S., Handberg, E. M., Zhou, Y., & Chandler, B. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.07.017 · Cited by 157
Cubbon, R. M., Gale, C. P., Kearney, L. C., Schechter, C. B., Brooksby, W. P., Nolan, J., Fox, K. A. A., Rajwani, A., Baig, W., Groves, D., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959882 · Cited by 132
Dickstein, K., Normand, C., Auricchio, A., Bogale, N., Cleland, J. G. F., Gitt, A. K., Stellbrink, C., Anker, S. D., Filippatos, G. S., Gasparini, M., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1142 · Cited by 144
Kusumoto, F. M., Calkins, H. G., BOEHMER, J. P., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J. H., Lee, R., Mehra, M. R., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000056 · Cited by 144
Self-citationReversal of Global Apoptosis and Regional Stress Kinase Activation by Cardiac Resynchronization
Chakir, K., Daya, S. K., Tunin, R. S., Helm, R. H., BYRNE, M. J., Dimaano, V. L. J., Lardo, A. C., Abraham, T. P., Tomaselli, G. F., & Kass, D. A. (2008) · Circulation · doi:10.1161/circulationaha.107.706291 · Cited by 130
Self-citationSPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony
Chen, J., Garcia, E. V., Bax, J. J., Iskandrian, A. E., Borges‐Neto, S., & Soman, P. (2011) · Journal of Nuclear Cardiology · doi:10.1007/s12350-011-9392-x · Cited by 131
Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure
Santangeli, P., Rame, J. E., Birati, E. Y., & Marchlinski, F. E. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.047 · Cited by 145
Bozkurt, B., & Khalaf, S. Z. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-4-216 · Cited by 157
Vannan, M. A., Pedrizzetti, G., Li, P., Gurudevan, S., Houle, H. C., Main, J., Jackson, J. I., & Nanda, N. C. (2005) · Echocardiography · doi:10.1111/j.1540-8175.2005.00172.x · Cited by 129
Metadata
- Authors
- Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., DeVries, D. W., & Feldman, A. M.
- Affiliations
- University of Colorado Health (US)
- University of Southern California (US)
- Penn State Milton S. Hershey Medical Center (US)
- Bryan Health (US)
- Johns Hopkins Hospital (US)
- Veterans Health Administration (US)
- Pfizer (United States) (US)
- University of Wisconsin–Madison (US)
- Thomas Jefferson University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-20
- Volume
- 350
- Issue
- 21
- Pages
- 2140-2150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130907431
- Cited by
- 5,812
- References
- 22
- Citations by year
- 2026: 80 · 2025: 126 · 2024: 131 · 2023: 179 · 2022: 149 · 2021: 157 · 2020: 196 · 2019: 213 · 2018: 210 · 2017: 265 · 2016: 260 · 2015: 308 · 2014: 276 · 2013: 323 · 2012: 350
- FWCI
- 240.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Keywords
- cardiac resynchronization therapy, implantable cardioverter-defibrillator, advanced chronic heart failure, intraventricular conduction delay, heart failure hospitalization, mortality, cardiomyopathy, QRS duration, pharmacotherapy
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Chronic Disease, Combined Modality Therapy, Diuretics, Female, Heart Failure, Hospitalization, Humans, Male, Pacemaker, Artificial, Risk, Spironolactone, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.